Cupertino, CA, United States of America

Ann K Wainright


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 294(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ann K Wainright: Innovator in Microfluidic Technology

Introduction

Ann K Wainright is a prominent inventor based in Cupertino, CA (US). She has made significant contributions to the field of microfluidic devices, holding 2 patents that showcase her innovative approaches to electrokinetic processes.

Latest Patents

Her latest patents include a method for closed-loop control of electrokinetic processes in microfluidic devices based on optical readings. This method involves applying an electric field to move a sample along a channel, concentrating it through the electric field application. The sample's location is optically monitored, allowing for automatic adjustments to the electric field to manipulate the sample further. Another notable patent involves methods and compositions for controlling the direction and transport of materials on microfluidic devices. This method utilizes an electrokinesis buffer containing a charged hydrophilic polymer, enhancing the transport of proteins and differentially charged chemical species.

Career Highlights

Ann K Wainright is currently associated with Aclara Biosciences, Inc., where she continues to advance her research in microfluidic technologies. Her work has significant implications for various applications, including the separation of polypeptides and conducting assays involving enzyme reactions.

Collaborations

Throughout her career, Ann has collaborated with notable colleagues such as Irene Visser and Sharat Singh, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ann K Wainright's contributions to microfluidic technology exemplify her dedication to advancing scientific knowledge and practical applications in the field. Her innovative patents and collaborative efforts position her as a key figure in the ongoing development of microfluidic devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…